{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:39:45Z","timestamp":1783690785907,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Cancer Center","award":["1110190"],"award-info":[{"award-number":["1110190"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2014R1A2A2A01002553"],"award-info":[{"award-number":["2014R1A2A2A01002553"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.clml.2016.06.013","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T10:36:59Z","timestamp":1465641419000},"page":"527-535.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5963-1577","authenticated-orcid":false,"given":"Seo Yeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyewon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Soon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoeun","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-Seok","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boram","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Young","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2016.06.013_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/01.moh.0000203191.99447.98","article-title":"Allogeneic hematopoietic stem cell transplantation for myelofibrosis","volume":"13","author":"Barosi","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.clml.2016.06.013_bib2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/CCO.0000000000000137","article-title":"Allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes","volume":"26","author":"Bart-Smith","year":"2014","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clml.2016.06.013_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11912-013-0340-6","article-title":"Hematopoietic stem cell transplantation for acute myeloid leukemia: to whom, when, and how","volume":"15","author":"Magenau","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.clml.2016.06.013_bib4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.bmt.1704966","article-title":"Immune restoration following hematopoietic stem cell transplantation: an evolving target","volume":"35","author":"Auletta","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2016.06.013_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbmt.2014.12.004","article-title":"Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation","volume":"21","author":"Uhlving","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2016.06.013_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbmt.2014.09.009","article-title":"Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital","volume":"21","author":"Wang","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2016.06.013_bib7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2016.06.013_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.coi.2006.06.002","article-title":"Improving outcome of allogeneic stem cell transplantation by immunomodulation of the early post-transplant environment","volume":"18","author":"Barrett","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.clml.2016.06.013_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ajh.23695","article-title":"White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcome","volume":"89","author":"Kim","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2016.06.013_bib10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/10428194.2013.823491","article-title":"Lymphocyte recovery on day 100 after allogeneic hematopoietic stem cell transplant predicts non-relapse mortality in patients with acute leukemia or myelodysplastic syndrome","volume":"55","author":"Yamamoto","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2016.06.013_bib11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/bmt.2012.143","article-title":"Biomarkers for acute GVHD: can we predict the unpredictable?","volume":"48","author":"Chen","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2016.06.013_bib12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/pbc.25347","article-title":"Impact of very early CD4(+)\/CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation","volume":"62","author":"Huttunen","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2016.06.013_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.beha.2006.09.009","article-title":"Immune reconstitution following hematopoietic stem-cell transplantation","volume":"20","author":"Geddes","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.clml.2016.06.013_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bmt.1705891","article-title":"Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia","volume":"41","author":"Ishaqi","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2016.06.013_bib15","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.3324\/haematol.2014.108407","article-title":"Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"99","author":"Kheav","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2016.06.013_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.clml.2016.06.013_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbmt.2011.07.024","article-title":"Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study","volume":"18","author":"Armand","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2016.06.013_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/bmt.2009.253","article-title":"Multicenter validation study of a transplantation-specific cytogenetics grouping scheme for patients with myelodysplastic syndromes","volume":"45","author":"Armand","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2016.06.013_bib19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2012-03-418202","article-title":"A\u00a0disease risk index for patients undergoing allogeneic stem cell transplantation","volume":"120","author":"Armand","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.06.013_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/sj.bmt.1705381","article-title":"Rapid helper T-cell recovery above 200\u00a0\u00d7 10 6\/L at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation","volume":"37","author":"Kim","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2016.06.013_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1096-8652(199702)54:2<131::AID-AJH6>3.0.CO;2-Y","article-title":"Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts","volume":"54","author":"Storek","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2016.06.013_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.bmt.1705871","article-title":"Lymphocyte subset recovery following allogeneic bone marrow transplantation: CD4(+)-cell count and transplant-related mortality","volume":"41","author":"Talmadge","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2016.06.013_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3345\/kjp.2013.56.1.26","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation in children: a single institution study of 59 patients","volume":"56","author":"Kim","year":"2013","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.clml.2016.06.013_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbmt.2014.01.001","article-title":"Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation","volume":"20","author":"Servais","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2016.06.013_bib25","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1182\/blood-2008-06-165506","article-title":"Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease","volume":"113","author":"Pillai","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.06.013_bib26","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1002\/eji.200324254","article-title":"Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection","volume":"33","author":"Kawakami","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.clml.2016.06.013_bib27","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1126\/science.270.5243.1845","article-title":"Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production","volume":"270","author":"Yoshimoto","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.clml.2016.06.013_bib28","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.184.4.1285","article-title":"Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells","volume":"184","author":"Bendelac","year":"1996","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.clml.2016.06.013_bib29","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/sj.leu.2404892","article-title":"Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia","volume":"21","author":"Savani","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2016.06.013_bib30","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbmt.2009.05.015","article-title":"Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies","volume":"15","author":"Le Blanc","year":"2009","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265016301185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265016301185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:27:27Z","timestamp":1761870447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265016301185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2152265016301185"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2016.06.013","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2016.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}